Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

TOOLS

Top Smart Score Stocks

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

PSTX

Company AnnouncementsPoseida Therapeutics Undergoes Merger and Delisting Changes

12d ago

PSTX

PremiumMarket News

Roche Finalizes Tender Offer for $1.5B Poseida Deal

12d ago

PSTX

PremiumThe Fly

Roche commences tender offer for outstanding Poseida shares at $9 per share

1M ago

PSTX

PremiumThe Fly

Poseida Therapeutics highlights interim Phase 1 results for P-BCMA-ALLO1

1M ago

PSTX

PremiumThe Fly

Poseida Therapeutics downgraded to Neutral from Overweight at Piper Sandler

2M ago

PSTX

PremiumMarket NewsPoseida Therapeutics (NASDAQ:PSTX) Stock Skyrockets on News of Roche Holdings Acquisition

2M ago

PSTX

Trump threatens tariffs, Zoom reports Q3 beat: Morning Buzz

Premium

The Fly

Trump threatens tariffs, Zoom reports Q3 beat: Morning Buzz

2M ago

Poseida Therapeutics downgraded to Neutral from Buy at H.C. Wainwright

Premium

The Fly

Poseida Therapeutics downgraded to Neutral from Buy at H.C. Wainwright

2M ago

PSTX

PremiumThe Fly

Poseida downgraded to Market Perform from Outperform at William Blair

2M ago

PSTX

PremiumThe Fly

Poseida Therapeutics downgraded to Neutral from Buy at BTIG

2M ago

PSTX

PremiumThe Fly

Poseida Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald

2M ago

PSTX

PremiumThe Fly

Poseida Therapeutics to be acquired by Roche for $9.00 per share plus CVR

2M ago

PSTX

PremiumCompany AnnouncementsPoseida Therapeutics Advances in Cell Therapy Innovations

2M ago

PSTX

Poseida Therapeutics holds virtual R&D Day

Premium

The Fly

Poseida Therapeutics holds virtual R&D Day

2M ago

PSTX

Poseida Therapeutics Reports Strong Q3 2024 Progress

Premium

Company Announcements

Poseida Therapeutics Reports Strong Q3 2024 Progress

2M ago

PSTX

PremiumThe Fly

Poseida Therapeutics reports Q3 EPS 21c, consensus 41c

2M ago

PSTX

PremiumThe Fly

Poseida Therapeutics to present data on P-KLKB1-101 in hereditary angioedema

3M ago

PSTX

PremiumThe Fly

Poseida Therapeutics nominates new CAR-T candidate under Roche collaboration

3M ago

PSTX

PremiumThe Fly

Poseida Therapeutics reports data from Phase 1 trial of P-BCMA-ALLO1

4M ago

PSTX

PremiumThe FlyPoseida Therapeutics says FDA grants RMAT designation to P-BCMA-ALLO1

4M ago

PSTX

Poseida Therapeutics initiates P-BCMA-ALLO1 Phase 1b trial

Premium

The Fly

Poseida Therapeutics initiates P-BCMA-ALLO1 Phase 1b trial

5M ago

PSTX

Poseida Therapeutics’ P-BCMA-101 shows efficacy in published case study

Premium

The Fly

Poseida Therapeutics’ P-BCMA-101 shows efficacy in published case study

5M ago

PSTX

PSTX

Trending

Indices

Stocks

ETFs